STOCK TITAN

Taro to Release First Quarter Results on July 27, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) will release its financial results for Q1 ending June 30, 2022, on July 27, 2022, after market close. This release will be available on www.taro.com.

The company focuses on providing high-quality healthcare products, emphasizing discovery, development, and manufacturing.

Positive
  • Scheduled financial results release may boost investor confidence.
  • Focus on high-quality healthcare products could drive long-term growth.
Negative
  • None.

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the first quarter ended June 30, 2022, after the close of market on Wednesday, July 27, 2022.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

William J. Coote

VP, Chief Financial Officer

(914) 345-9001

William.Coote@taro.com

Source: Taro Pharmaceutical Industries Ltd.

FAQ

When will Taro Pharmaceutical release its financial results for Q1 2022?

Taro Pharmaceutical will release its financial results for Q1 2022 on July 27, 2022, after market close.

What date does Taro Pharmaceutical's Q1 2022 financial period end?

The financial period for Taro Pharmaceutical's Q1 2022 ended on June 30, 2022.

Where can I find Taro Pharmaceutical's financial results?

Taro Pharmaceutical's financial results will be accessible on their website at www.taro.com.

Taro Pharmaceutical Industries Ltd.

NYSE:TARO

TARO Rankings

TARO Latest News

TARO Stock Data

1.62B
8.09M
78.48%
13.06%
0.2%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Haifa